Viewing Study NCT04895020

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-04-18 @ 7:12 AM
Study NCT ID: NCT04895020
Status: RECRUITING
Last Update Posted: 2024-04-17
First Post: 2021-05-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HPV Infections View
None Cervical Cancer View
None Vulvar Cancer View
None Vaginal Cancer View
None CIN1 View
None CIN2 View
None CIN 3 View
None VaIN1 View
None VaIN2 View
None VaIN3 View
None Genital Wart View
None VIN 1 View
None VIN 2 View
None VIN 3 View
None AIS View
Keywords: